Arcturus Therapeutics Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:$88.2M
Industry:Biotech
Founded:2013
Lead Investor(s):Cystic Fibrosis Foundation Therapeutics

City Ranking

Industry Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • Arcturus Therapeutics's estimated annual revenue is currently $15.7M per year.
  • Arcturus Therapeutics received $3.0M in venture funding in May 2017.
  • Arcturus Therapeutics's estimated revenue per employee is $155,000
  • Arcturus Therapeutics's total funding is $88.2M.

Employee Data

  • Arcturus Therapeutics has 101 Employees.
  • Arcturus Therapeutics grew their employee count by 26% last year.
  • Arcturus Therapeutics currently has 13 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$7M4510%N/A-N/A
#2
N/A205N/AN/A-N/A
#3
$46.8M3024%N/A-N/A
#4
$22.3M144N/AN/A-N/A
#5
$44.3M286N/AN/A-N/A
#6
$101.2M65346%N/A-N/A
#7
$18.6M120N/AN/A-N/A
#8
$23.3M150N/AN/A-N/A
#9
$33.3M2153%N/A-N/A
#10
$28.7M1858%N/A-N/A
Missing a competitor? Contribute!?
Submit

Arcturus Therapeutics is a preclinical drug delivery and nucleic acid medicines company. We are focused on developing novel technologies to build the next generation of safe, effective RNA and DNA medicines. We have proprietary technologies, validating partnerships, and an experienced team with deep expertise in delivery and nucleic acid-based therapeutics. Arcturus Therapeutics is presently recruiting outstanding candidates with experience in the field of RNA technologies and nanoparticle sciences. Only exceptional applicants need apply. Compensation and equity position is commensurate. Please email your resume to Careers@ArcturusRx.com, or visit https://arcturusrx.com/careers/

keywords:Biotechnology,Healthcare,Pharmaceuticals

101

Number of Employees

$15.7M

Revenue (est)

13

Current Jobs

26%

Employee Growth %

$88.2M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

Arcturus Therapeutics News

09/03/2019 - Arcturus Therapeutics Announces Second Quarter Financial ...

15, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (“Arcturus Therapeutics”) (NASDAQ: ARCT), a leading messenger RNA ...

09/08/2019 - Arcturus Therapeutics To Present at Two Investor Conferences in September

SAN DIEGO, Aug. 26, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Holdings Inc. (“Arcturus Therapeutics”) (ARCT), a leading ...

09/03/2019 - Aug 26, 2019 - Arcturus Therapeutics Holdings Inc (ARCT) CFO Andy Sassine Bought $109,000 of Shares

CFO of Arcturus Therapeutics Holdings Inc (30-Year Financial, Insider Trades) Andy Sassine (insider trades) bought 10,000 shares of ARCT on ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
#1
$25.4M10113%$121.3M-N/A
#2
$14.8M102N/AN/A3.8/5N/A
#3
$12.2M102N/AN/A-N/A
#4
$10.4M102N/AN/A-N/A
#5
$15.8M1027%N/A-N/A

Arcturus Therapeutics Funding

DateAmountRoundLead InvestorsReference
2013-06-04$1.3MUndisclosedArticle
2013-10-02$2.1MUndisclosedArticle
2013-10-22$5.0MAArticle
2017-05-31$3.0MUndisclosedCystic Fibrosis Foundation TherapeuticsArticle

Arcturus Therapeutics Executive Hires

DateNameTitleReference
2013-10-29Zachary A. ZimmermanChief Business OfficerArticle
2018-02-13Christine EsauVice President of Research and DevelopmentArticle
2018-08-29Andrew SassineInterim Chief Financial OfficerArticle

Arcturus Therapeutics New Location/Offices

DateLocationReference
2014-11-04San Diego, CAArticle